Literature DB >> 21511808

3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.

Patrizia Agretti1, Giuseppina De Marco, Laura Russo, Alessandro Saba, Andrea Raffaelli, Maja Marchini, Grazia Chiellini, Lucia Grasso, Aldo Pinchera, Paolo Vitti, Thomas S Scanlan, Riccardo Zucchi, Massimo Tonacchera.   

Abstract

3-Iodothyronamine (T(1)AM), produced from thyroid hormones (TH) through decarboxylation and deiodination, is a potent agonist of trace amine-associated receptor 1 (TAAR1), a G protein-coupled receptor belonging to the family of TAARs. In vivo T(1)AM induces functional effects opposite to those produced on a longer time scale by TH and might represent a novel branch of TH signaling. In this study, we investigated the action of T(1)AM on thyroid and determined its uptake and catabolism using FRTL5 cells. The expression of TAAR1 was determined by PCR and western blot in FRTL5 cells, and cAMP, iodide uptake, and glucose uptake were measured after incubation with increasing concentrations of T(1)AM for different times. T(1)AM and its catabolites thyronamine (T(0)AM), 3-iodothyroacetic acid (TA(1)), and thyroacetic acid (TA(0)) were analyzed in FRTL5 cells by HPLC coupled to tandem mass spectrometry. The product of amplification of TAAR1 gene and TAAR1 protein was demonstrated in FRTL5 cells. No persistent and dose-dependent response to T(1)AM was observed after treatment with increasing doses of this substance for different times in terms of cAMP production and iodide uptake. A slight inhibition of glucose uptake was observed in the presence of 100 μM T(1)AM after 60 and 120 min (28 and 32% respectively), but the effect disappeared after 18 h. T(1)AM was taken up by FRTL5 cells and catabolized to T(0)AM, TA(1), and TA(0) confirming the presence of deiodinase and amine oxidase activity in thyroid. In conclusion, T(1)AM determined a slight inhibition of glucose uptake in FRTL5 cells, but it was taken up and catabolized by these cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511808     DOI: 10.1530/JME-10-0168

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  9 in total

1.  Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.

Authors:  Latha Durai; Soundharya Ravindran; Krishnamurthy Arvind; Devarajan Karunagaran; Ramshankar Vijayalakshmi
Journal:  Mol Biol Rep       Date:  2021-10-30       Impact factor: 2.316

2.  3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo.

Authors:  Carolin S Hoefig; Simon F Jacobi; Amy Warner; Lisbeth Harder; Nancy Schanze; Björn Vennström; Jens Mittag
Journal:  Br J Pharmacol       Date:  2015-06-09       Impact factor: 8.739

3.  Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS.

Authors:  Daniel Rathmann; Eddy Rijntjes; Julika Lietzow; Josef Köhrle
Journal:  Eur Thyroid J       Date:  2015-05-28

4.  Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism.

Authors:  Claudia Musilli; Gaetano De Siena; Maria Elena Manni; Andrea Logli; Elisa Landucci; Riccardo Zucchi; Alessandro Saba; Riccardo Donzelli; Maria Beatrice Passani; Gustavo Provensi; Laura Raimondi
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 5.  Update on 3-iodothyronamine and its neurological and metabolic actions.

Authors:  Riccardo Zucchi; Alice Accorroni; Grazia Chiellini
Journal:  Front Physiol       Date:  2014-10-16       Impact factor: 4.566

Review 6.  G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids.

Authors:  Chen Wang; Yi Liu; Ji-Min Cao
Journal:  Int J Mol Sci       Date:  2014-09-01       Impact factor: 5.923

7.  A validated LC-MS/MS method for cellular thyroid hormone metabolism: Uptake and turnover of mono-iodinated thyroid hormone metabolites by PCCL3 thyrocytes.

Authors:  Keith H Richards; Nancy Schanze; Ray Monk; Eddy Rijntjes; Daniel Rathmann; Josef Köhrle
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

8.  Canonical TSH Regulation of Cathepsin-Mediated Thyroglobulin Processing in the Thyroid Gland of Male Mice Requires Taar1 Expression.

Authors:  Maria Qatato; Joanna Szumska; Vladislav Skripnik; Eddy Rijntjes; Josef Köhrle; Klaudia Brix
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

Review 9.  Similarities and Differences in the Peripheral Actions of Thyroid Hormones and Their Metabolites.

Authors:  Ruy A Louzada; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.